Advertisement

Topics

A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa

11:21 EST 21 Feb 2017 | Labiotech.eu

Apitope is developing therapeutic peptides to induce suppression of autoimmune responses towards self-antigens. Their recent phase IIa trial has revealed promising results for the treatment of multiple sclerosis. Multiple sclerosis (MS) is a hot topic these days. While a recent long-term study revealed the ...

This awesome article A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa

NEXT ARTICLE

More From BioPortfolio on "A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...